These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 31737971)

  • 1. Management of unilateral head and neck carcinoma of unknown primary: Retrospective analysis of the impact of postoperative radiotherapy target volumes.
    Podeur F; Pommier P; Crozes C; Monchet E; Ton Van J; Roux PE; Poupart M; Zrounba P; Julieron M; Deneuve S
    Head Neck; 2020 Feb; 42(2):302-311. PubMed ID: 31737971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of postoperative radiotherapy target volumes in unilateral head and neck carcinoma of unknown primary: A multicentric study using propensity score.
    Brenet E; Philouze P; Schiffler C; Pommier P; Crozes C; Benzerdjeb N; Monchet E; Boulagnon-Rombi C; Ton Van J; Podeur F; Servagi-Vernat S; Liem X; Merol JC; Ceruse P; Serre AA; Chabaud S; Julieron M; Deneuve S
    Radiother Oncol; 2021 Jul; 160():1-8. PubMed ID: 33845043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Head and neck squamous cell carcinoma of unknown primary: neck dissection and radiotherapy or definitive radiotherapy.
    Demiroz C; Vainshtein JM; Koukourakis GV; Gutfeld O; Prince ME; Bradford CR; Wolf GT; McLean S; Worden FP; Chepeha DB; Schipper MJ; McHugh JB
    Head Neck; 2014 Nov; 36(11):1589-1595. PubMed ID: 23996575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unilateral or bilateral irradiation in cervical lymph node metastases of unknown primary? A retrospective cohort study.
    Pflumio C; Troussier I; Sun XS; Salleron J; Petit C; Caubet M; Beddok A; Calugaru V; Servagi-Vernat S; Castelli J; Miroir J; Krengli M; Giraud P; Romano E; Khalifa J; Doré M; Blanchard N; Coutte A; Dupin C; Sumodhee S; Pointreau Y; Patel S; Rehailia-Blanchard A; Catteau L; Bensadoun RJ; Tao Y; Roth V; Geoffrois L; Faivre JC; Thariat J
    Eur J Cancer; 2019 Apr; 111():69-81. PubMed ID: 30826659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patterns of Failure in Patients With Head and Neck Squamous Cell Carcinomas of Unknown Primary Treated With Chemoradiotherapy.
    Dhouib F; Bertaut A; Maingon P; Siala W; Daoud J; Aubignac L; Lestrade L; Crehange G; Vulquin N
    Technol Cancer Res Treat; 2020; 19():1533033820905826. PubMed ID: 32484037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term results of elective mucosal irradiation for head and neck cancer of unknown primary in Chinese population: The EMICUP study.
    Dou S; Li R; Zhang L; Wang Z; Xie L; Zhang C; Zhu G
    Cancer Med; 2020 Mar; 9(5):1712-1720. PubMed ID: 31953927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of target volumes and radiation technique on loco-regional control and survival for patients with unilateral cervical lymph node metastases from an unknown primary.
    Ligey A; Gentil J; Créhange G; Montbarbon X; Pommier P; Peignaux K; Truc G; Maingon P
    Radiother Oncol; 2009 Dec; 93(3):483-7. PubMed ID: 19892420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer of unknown primary (CUP) of the head and neck: retrospective analysis of 81 patients.
    Al Kadah B; Papaspyrou G; Linxweiler M; Schick B; Rübe C; Büchler BS; Niewald M
    Eur Arch Otorhinolaryngol; 2017 Jun; 274(6):2557-2566. PubMed ID: 28314959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unknown primary head and neck cancer treated with intensity-modulated radiation therapy: to what extent the volume should be irradiated.
    Lu H; Yao M; Tan H
    Oral Oncol; 2009 Jun; 45(6):474-9. PubMed ID: 18804408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tailored multimodality therapy guided by a two-step decision making process for head-and-neck cancer of unknown primary.
    Dou S; Qian W; Ji Q; Wang Z; Zhu G
    Oncotarget; 2016 Jun; 7(26):40095-40105. PubMed ID: 27223430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of the unknown primary carcinoma: long-term follow-up on a negative PET scan and negative panendoscopy.
    Miller FR; Karnad AB; Eng T; Hussey DH; Stan McGuff H; Otto RA
    Head Neck; 2008 Jan; 30(1):28-34. PubMed ID: 17657782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patterns of failure in patients with head and neck carcinoma of unknown primary treated with radiation therapy.
    Cuaron J; Rao S; Wolden S; Zelefsky M; Schupak K; Mychalczak B; Lee N
    Head Neck; 2016 Apr; 38 Suppl 1(Suppl 1):E426-31. PubMed ID: 25581274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation between fluorodeoxyglucose hotspots on pretreatment positron emission tomography/CT and preferential sites of local relapse after chemoradiotherapy for head and neck squamous cell carcinoma.
    Chaput A; Calais J; Robin P; Thureau S; Bourhis D; Modzelewski R; Schick U; Vera P; Salaün PY; Abgral R
    Head Neck; 2017 Jun; 39(6):1155-1165. PubMed ID: 28263422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metastatic carcinoma in the cervical lymph nodes from an unknown primary site: results of bilateral neck plus mucosal irradiation vs. ipsilateral neck irradiation.
    Reddy SP; Marks JE
    Int J Radiat Oncol Biol Phys; 1997 Mar; 37(4):797-802. PubMed ID: 9128954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unknown primary squamous cell carcinoma of the head and neck: retrospective analysis of 80 cases.
    Mizuta M; Kitamura M; Tateya I; Tamaki H; Tanaka S; Asato R; Shinohara S; Takebayashi S; Maetani T; Kitani Y; Kumabe Y; Kojima T; Ushiro K; Ichimaru K; Honda K; Yamada K; Omori K
    Acta Otolaryngol; 2018 Jun; 138(6):590-596. PubMed ID: 29310489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cervical lymph node metastases from occult squamous cell carcinoma: cut down a tree to get an apple?
    Nieder C; Gregoire V; Ang KK
    Int J Radiat Oncol Biol Phys; 2001 Jul; 50(3):727-33. PubMed ID: 11395241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recurrences near base of skull after IMRT for head-and-neck cancer: implications for target delineation in high neck and for parotid gland sparing.
    Eisbruch A; Marsh LH; Dawson LA; Bradford CR; Teknos TN; Chepeha DB; Worden FP; Urba S; Lin A; Schipper MJ; Wolf GT
    Int J Radiat Oncol Biol Phys; 2004 May; 59(1):28-42. PubMed ID: 15093896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of 18-Fludeoxyglucose positron emission tomography-computed tomography and subsequent panendoscopy in head and neck squamous cell carcinoma of unknown primary.
    Mani N; George MM; Nash L; Anwar B; Homer JJ
    Laryngoscope; 2016 Jun; 126(6):1354-8. PubMed ID: 26671043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The management of metastatic squamous cell carcinoma in cervical lymph nodes from an unknown primary.
    Medini E; Medini AM; Lee CK; Gapany M; Levitt SH
    Am J Clin Oncol; 1998 Apr; 21(2):121-5. PubMed ID: 9537194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharyngeal-sparing radiation for head and neck carcinoma of unknown primary following TORS assisted work-up.
    Grewal AS; Rajasekaran K; Cannady SB; Chalian AA; Ghiam AF; Lin A; LiVolsi V; Lukens JN; Mitra N; Montone KT; Newman JG; O'Malley BW; Rassekh CH; Weinstein GS; Swisher-McClure S
    Laryngoscope; 2020 Mar; 130(3):691-697. PubMed ID: 31411747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.